Recognition of patients with cardiovascular disease by artificial neural networks

Annals of Medicine

Volumn 36, Issue 8, 2004, Pages 630-640

  Baldassarre, Damiano ^a,d   Grossi, Enzo ^c   Buscema, Massimo ^b   Intraligi, Marco ^b   Amato, Mauro ^d   Tremoli, Elena ^a,d   Pustina, Linda ^a   Castelnuovo, Samuela ^a   Sanvito, Silvia ^a   Gerosa, Lorenzo ^a   Sirtori, Cesare R ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Semeion centro ricerche di scienze della communicazione   (Italy)

^c Bracco Imaging SpA   (Italy)

^d CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

Artificial intelligence; Diagnosis; Intima media thickness; Neural networks

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ARTIFICIAL INTELLIGENCE; ARTIFICIAL NEURAL NETWORK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COMPUTER PREDICTION; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECOGNITION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAROTID ARTERY, COMMON; CAROTID ARTERY, INTERNAL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 19944421721     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890410018880     Document Type: Article

References (47)

1. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1990;121:293-8.
2. Schulte H, Assmann G. CHD risk equations, obtained from the Framingham Heart Study, applied to the PROCAM Study. Cardiovasc Risk Factors 1991;1:126-33.
3. Thomsen TF, Davidsen M, Jorgensen HIT, Jensen G, Borch-Johnsen K. A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score. J Cardiovasc Risk 2001;8:291-7.
4. Kwame O, Akosah MD, Schaper A, Cogbill C, Schoenfeld P. Preventing Myocardial Infarction in the Young Adult in the First Place: How Do the National Cholesterol Education Panel III Guidelines Perform? J Am Coll Cardiol 2003;41: 1475-9.
5. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women. The British Regional Heart Study. Stroke 1999;30:841-50.
6. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction. The Rotterdam Study. Circulation 1997;96:1432-7.
7. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22.
8. Bots ML, Hoes AW, Hofman A, Witteman JC, Grobbee DE. Cross-sectionally assessed carotid intima-media thickness relates to long-term risk of stroke, coronary heart disease and death as estimated by available risk functions. J Intern Med 1999;245:269-76.
9. Joakimsen O, Bonaa KH, Mathiesen EB, Stensland-Bugge E, Arnesen E. Prediction of mortality by ultrasound screening of a general population for carotid stenosis: the Tromso Study. Stroke 2000;31:1871-6.
10. Balbarini A, Buttitta F, Limbruno U, Petronio AS, Baglini R, Strata G, et al. Usefulness of carotid intima-media thickness measurement and peripheral B-mode ultrasound scan in the clinical screening of patients with coronary artery disease. Angiology 2000;51:269-79.
11. Del Sol AI, Moons KG, Hollander M, Hofman A, Koudstaal PJ, Grobbee DE, et al. Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke 2001;32:1532-8.
12. Cross SS, Harrison RF, Kennedy RL. Introduction to neural networks. Lancet 1995;346:1075-9.
13. Itchhaporia D, Snow P, Almassy R, Oetgen WJ. Artificial neural networks: current status in cardiovascular medicine. J Am Coll Cardiol 1996;28:515-21.
14. Doig GS, Inman KJ, Sibbald WJ, Martin CM, Robertson JM. Modeling mortality in the intensive care unit: comparing the performance of a back-propagation, associative-learning neural network with multivariate logistic regression. In: Proc Annu Symp Comput Appl Med Care 1993:361-5.
15. Ebell MH. Artificial neutral networks for predicting failure to survive following in-hospital cardiopulmonary resuscitation. J Fam Pract 1993;36:297-303.
16. Snow PB, Smith DS, Catalona WJ. Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. J Urol 1994;152:1923-6.
17. Page MP, Howard RJ, O'Brien JT, Buxton-Thomas MS, Pickering AD. Use of neural networks in brain SPECT to diagnose Alzheimer's disease. J Nucl Med 1996;37:195-200.
18. Hopkins CB, Suleman J, Cook C. An artificial neural network for the electrocardiographic diagnosis of left ventricular hypertrophy. Crit Rev Biomed Eng 2000;28:435-8.
19. Scott JA, Palmer EL, Fishman AJ. How well can radiologist using neural network software diagnose pulmonary embolism? Am J Roentgenol 2000;175:399-405.
20. Finne P, Finne R, Auvinen A, Juusela H, Maattanen L, Hakama M, et al. Predicting the outcome of prostate biopsy in screen-positive men by a multiplayer perception network. Urology 2000;56:418-22.
21. Voss R, Cullen P, Schulte H, Assmann G. Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Munster Study (PROCAM) using neural networks. Int J Epidemiol. 2002;31:1253-62.
22. Baxt WG, Shofer FS, Sites FD, Hollander JE. A neural computational aid to the diagnosis of acute myocardial infarction. Ann Emerg Med 2002;39:366-73.
23. Beaumont JL, Carlson LA, Cooper GR, Fejfar Z, Fredrickson DS, Strasser T. Classification of hyperlipidemias and hyperlipoproteinemias. Bull World Health Organ 1970;43:891-915.
24. Bucolo G, David M. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19:476-82.
25. Röschlau P, Bernt E, Gruber W. Enzymatische Bestimmung des Gesamt Cholesterins in Serum. Z Klin Chem Klin Biochem 1974;12:403-7.
26. Warnick GR, Benderson J, Albers JJ. Dextran sulfate precipitation procedure for quantitation of high density lipoproteins. Clin Chem 1982;28:1379-88.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
28. Baldassarre D, Amato M, Bondioli A, Sirtori CR, Tremoli E. Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke 2000;31:2426-30.
29. Buscema M. Theory: Foundation of Artificial Neural Networks. Subst Use Misuse 1998;33:28-98.
30. Buscema M. Back Propagation Neural Networks. Subst Use Misuse 1998;33:233-70.
31. Rumelhart DE, McClelland JL, (eds). Parallel Distributed Processing: Explorations in the microstructure of cognition. Vol. 1: Foundations. Vol. 2: Psychological and biological models. Cambridge, MA: MIT Press/Bradford Books; 1986.
32. Breda M, Buscema M. Recurrent Neural Networks. In Buscema and Semeion Group, Artificial Neural Networks and Social Complex System, Vol. I. Milan: Franco Angeli; 1999:452-64 (in Italian).
33. Dietterich TG. Approximate statistical tests for comparing supervised classification learning algorithms,. Neural Comput 1998;10:1895-924.
34. Lapuerta P, Azen SP, LaBree L. Use of neural networks in predicting the risk of coronary artery disease. Comput Biomed Res 1995;28:38-52.
35. Buchman TG, Kubos KL, Seidler AJ, Siegforth MJ. A comparison of statistical and connectionist models for the prediction of chronicity in a surgical intensive care unit. Crit Care Med 1994;22:750-62.
36. Edwards DF, Hollingsworth H, Zazulia AR, Diringer MN. Artificial neural networks improve the prediction of mortality in intracerebral hemorrhage. Neurology 1999;53:351-7.
37. White H. Learning in artificial neural networks: a statistical perspective. Neural Comput 1989;1:425-64.
38. Hinton G. How neural networks learn from experience. Sci Am 1992;267:145-51.
39. Ward Systems Group Neuroshell 2. Frederick, MO: Ward Systems Group; 1993.
40. Tu J. Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes. J Clin Epidemiol 1996;49:1225-31.
41. Tewari A. Artificial intelligence and neural networks: concept, applications and future in urology. Br J Urol 1997;80:53-8.
42. Ohno-Machado L, Rowland T. Neural network applications in physical medicine and rehabilitation. Am J Phys Med Rehabil 1999;78:392-8.
43. Bottaci L, Drew PJ, Hartley JE, Hadfield MB, Farouk R, Lee PW, et al. Artificial neural networks applied to outcome prediction for colorectal cancer patients in separate institutions. Lancet 1997;350:469-72.
44. Thayer JF, von Eye A, Rovine MJ. Assessment of neural network models using prediction analysis. Biomed Sci Instrum 1995;31:25-8.
45. Guerriere MR, Detsky AS. Neural networks: what are they? Ann Intern Med 1991;115:906-7.
46. Buscema M. Genetic Doping Algorithm. In Buscema and Semeion Group, Artificial Neural Networks and Social Complex System, vol. I. Milan: Franco Angeli; 1999:465-86.
47. Buscema M. Genetic Doping Algorithm (GenD): theory and applications. Expert Systems 2004;2:63-79.